BLEEDnFIRE Therapeutics is a Swiss early-stage biotechnology company specializing in differentiated first-in-class RNA-based therapies for rare bleeding disorders. Its lead asset, BnF-001, is a protein S-targeting siRNA therapeutic specifically designed to restore hemostasis across rare bleeding dis... Read more
Org chart
This company has no org chart yet
Teams
This company has no teams yet
Offices
This company has no offices yet
